相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA repair proteins as molecular targets for cancer therapeutics
Mark R. Kelley et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Institute of medicine's 10-point plan for more comprehensive cancer care
[Anonymous]
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
alpha-Methylacyl-CoA racemase - an 'obscure' metabolic enzyme takes centre stage
Matthew D. Lloyd et al.
FEBS JOURNAL (2008)
Hypoxia in prostate cancer: observation to intervention
Yaacov Richard Lawrence et al.
LANCET ONCOLOGY (2008)
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Markus Welcker et al.
NATURE REVIEWS CANCER (2008)
Opinion - Survivin, cancer networks and pathway-directed drug discovery
Dario C. Altieri
NATURE REVIEWS CANCER (2008)
Hypoxia, DNA repair and genetic instability
Robert G. Bristow et al.
NATURE REVIEWS CANCER (2008)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
ABT-888, an orallyactive poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K. Donawho et al.
CLINICAL CANCER RESEARCH (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
The Ndc80/HEC1 complex is a contact point for kinetochore-microtubule attachment
Ronnie R. Wei et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
DNA methylation pathway alterations in an autochthonous murine model of prostate cancer
Shannon R. Morey et al.
CANCER RESEARCH (2006)
The isopeptidase USP2a protects human prostate cancer from apoptosis
Carmen Priolo et al.
CANCER RESEARCH (2006)
Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity
Jonathan D. H. Morris et al.
CANCER LETTERS (2006)
Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2
Ashwin A. Dihal et al.
CANCER LETTERS (2006)
Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3)
M. R. Vijayababu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines
AQ Haddad et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
CSR1 suppresses tumor growth and metastasis of prostate cancer
GY Yu et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Targeting death receptors in bladder, prostate and renal cancer
HF O'Kane et al.
JOURNAL OF UROLOGY (2006)
Increased expression of osteopontin contributes to the progression of prostate cancer
AC Khodavirdi et al.
CANCER RESEARCH (2006)
Nutrigenomics and nutrigenetics: the emerging faces of nutrition
DM Mutch et al.
FASEB JOURNAL (2005)
ATP citrate lyase inhibition can suppress tumor cell growth
G Hatzivassiliou et al.
CANCER CELL (2005)
The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis
RA Cardone et al.
NATURE REVIEWS CANCER (2005)
ATP citrate lyase is an important component of cell growth and transformation
DE Bauer et al.
ONCOGENE (2005)
RNA interference-mediated silencing of the Acetyl-CoA-Carboxylase-α gene induces growth inhibition and apoptosis of prostate cancer cells
K Brusselmans et al.
CANCER RESEARCH (2005)
Molecular pathology of prostate cancer
C Hughes et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
The sweet and sour of cancer: Glycans as novel therapeutic targets
MM Fuster et al.
NATURE REVIEWS CANCER (2005)
EphB4 expression and biological significance in prostate cancer
GB Xia et al.
CANCER RESEARCH (2005)
Survivin mediates resistance to antiandrogen therapy in prostate cancer
M Zhang et al.
ONCOGENE (2005)
Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells
O Berezovskaya et al.
CANCER RESEARCH (2005)
Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity
K Brusselmans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Environmental, genetic, and molecular features of prostate cancer
E Deutsch et al.
LANCET ONCOLOGY (2004)
Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate
K Halkidou et al.
EUROPEAN UROLOGY (2004)
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
E Graner et al.
CANCER CELL (2004)
Biologically active sphingolipids in cancer pathogenesis and treatment
B Ogretmen et al.
NATURE REVIEWS CANCER (2004)
Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5′-monophosphate dehydrogenase
D Floryk et al.
CANCER RESEARCH (2004)
Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention
CD Davis et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2004)
Angiogenesis and prostate cancer tumor growth
B Nicholson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Molecular mechanisms of prostate cancer
KP Porkka et al.
EUROPEAN UROLOGY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro
NS Shenouda et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Dietary flavonoids and cancer risk: Evidence from human population studies
ML Neuhouser
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Novel molecular aspects of prostate carcinogenesis
HA Meyer et al.
BIOMEDICINE & PHARMACOTHERAPY (2004)
β-Catenin signaling in prostate cancer:: an early perspective
DR Chesire et al.
ENDOCRINE-RELATED CANCER (2003)
Flavonoid intake and breast cancer risk: a case-control study in Greece
J Peterson et al.
BRITISH JOURNAL OF CANCER (2003)
Mechanisms of disease: Prostate cancer
WG Nelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Flavonoids: Promising anticancer agents
WY Ren et al.
MEDICINAL RESEARCH REVIEWS (2003)
Nutrigenomics:: goals and strategies
M Müller et al.
NATURE REVIEWS GENETICS (2003)
Heat shock protein 90 as a molecular target for cancer therapeutics
JS Isaacs et al.
CANCER CELL (2003)
BCL-2 in prostate cancer: A minireview
SD Catz et al.
APOPTOSIS (2003)
Perlecan and tumor angiogenesis
XN Jiang et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
Sphingosine-1-phosphate: dual messenger functions
SG Payne et al.
FEBS LETTERS (2002)
Polyphenols in red wine inhibit the proliferation and induce apoptosis of LNCaP cells
I Romero et al.
BJU INTERNATIONAL (2002)
Effect of flavonoids on cell cycle progression in prostate cancer cells
T Kobayashi et al.
CANCER LETTERS (2002)
Dietary flavonols: Chemistry, food content, and metabolism
SA Aherne et al.
NUTRITION (2002)
Metastasis suppression in prostate cancer
EB Jaeger et al.
CANCER AND METASTASIS REVIEWS (2001)
Resveratrol and quercetin inhibit angiogenesis in vitro
K Igura et al.
CANCER LETTERS (2001)
Molecular properties and involvement of heparanase in cancer progression and normal development
I Vlodavsky et al.
BIOCHIMIE (2001)
Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis
E Zcharia et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2001)
Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells
NZ Xing et al.
CARCINOGENESIS (2001)
Ceramide glycosylation potentiates cellular multidrug resistance
YY Liu et al.
FASEB JOURNAL (2001)
Increased expression of cyclooxygenase-2 and nitric:: oxide synthase-2 in human prostate cancer
P Uotila et al.
UROLOGICAL RESEARCH (2001)
Intake of flavonoids and lung cancer
L Le Marchand et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
